Articles

TFF Pharmaceuticals Articles

October 28, 2020BioSpaceNews

TFF Pharmaceuticals Announces Third Quarter 2020 Financial Results and Business Update Conference Call on November 5, 2020

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on devel... See more »
October 27, 2020BioSpaceNews

TFF Pharmaceuticals Announces Positive Preclinical Results with University of Georgia Universal Influenza Vaccines

Company's Thin Film Freezing dry powder was equivalent to the liquid universal influenza formulated v... See more »
October 26, 2020Outsourcing-PharmaNews

TFF Pharmaceuticals partners with Experic to expand manufacturing

The clinical-stage pharma firm will install a processing line at Expericâs cGMP facility in New Jerse... See more »
October 20, 2020Business WirePress Release

TFF Pharmaceuticals Updates Progress of Human Clinical Trial with Tacrolimus Inhalation Powder

AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals updates progress of human clinical trial with Tac... See more »
October 6, 2020Contract PharmaNews

Irisys Signs Contract with TFF Pharma

Will produce medication to treat lung conditions, including COVID-19.... See more »
October 1, 2020MarketScreenerNews

Announces Results of Its 2020 Annual Meeting of Stockholders

(marketscreener.com) TFF Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused o... See more »
September 30, 2020BioSpaceNews

IRISYS LLC Signs a Third Contract with TFF Pharma to Produce Medication to Treat Lung Conditions, Including COVID-19

IRISYS LLC, a pharmaceutical contract manufacturing and development organization (CDMO), announced it... See more »
September 24, 2020Business WirePress Release

TFF Pharmaceuticals Comments on Animal Studies in the Development of High Potency Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing

AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals comments on animal studies in the development of ... See more »
September 16, 2020OINDPnewsNews

TFF to advance its dry powder voriconazole to Phase 2 after successful Phase 1 trial

TFF Pharmaceuticals has announced that it will advance its voriconazole inhalation powder into Phase ... See more »
September 15, 2020Business WirePress Release

TFF Pharmaceuticals Announces Topline Results of Voriconazole Inhalation Powder Phase 1 Clinical Trial

AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals (NASDAQ: TFFP) announces topline results of Voric... See more »
May 14, 2020centralchartsPress Release

TFF Pharmaceuticals Reports First Quarter 2020 Financial and Business Results

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on devel... See more »
May 14, 2020Business WirePress Release

TFF Pharmaceuticals Reports First Quarter 2020 Financial and Business Results

AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals reports first quarter 2020 financial and business... See more »
April 30, 2020centralchartsPress Release

TFF Pharmaceuticals' Inventor Dr. Robert O. Williams III Presents Session on Repurposing Niclosamide for COVID-19 Treatment at AAPS Meeting

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on devel... See more »
Loading interface...
Loading interface...
Loading interface...
Loading interface...